角质形成细胞癌不同种族医疗资源利用与费用差异
该研究基于1996至2015年美国医疗支出面板调查数据,比较非西班牙裔白人、西班牙裔白人和非西班牙裔黑人角质形成细胞癌患者的医疗利用与费用。结果显示西班牙裔白人和非西班牙裔黑人患者门诊就诊次数更多,非西班牙裔黑人患者急诊就诊、门诊费用、药物费用及总费用均显著更高。
要点
- 非西班牙裔黑人患者年均门诊13.1次,显著高于非西班牙裔白人的3.5次。
- 非西班牙裔黑人患者年均总费用13430美元,显著高于非西班牙裔白人的1290美元。
- 西班牙裔白人患者年均门诊5.4次,显著高于非西班牙裔白人的3.5次。
核心结论
- 非西班牙裔黑人和西班牙裔白人角质形成细胞癌患者比非西班牙裔白人患者需要更多医疗资源且治疗费用更高。
研究设计与样本
- 全国性横断面研究,使用1996至2015年医疗支出面板调查数据,加权后共纳入54,503,447例角质形成细胞癌患者。
主要发现
- 加权患者中非西班牙裔白人53,134,351例(97%),西班牙裔白人836,030例(1.5%),非西班牙裔黑人170,755例(0.3%)。
- 西班牙裔白人患者年均门诊就诊5.4次,显著多于非西班牙裔白人的3.5次(P = .003)。
- 非西班牙裔黑人患者年均门诊就诊13.1次(P = .027)和急诊就诊2.3次(P < .001),均显著多于非西班牙裔白人的3.5次和1.1次。
- 非西班牙裔黑人患者年均门诊费用5089美元(P = .05)、药物费用523美元(P = .022)和总费用13430美元(P = .032),均显著高于非西班牙裔白人的1131美元、221美元和1290美元。
临床怎么用
- 临床应关注非西班牙裔黑人和西班牙裔白人角质形成细胞癌患者的医疗资源利用差异,优化资源分配以改善服务不足人群的诊疗。
局限性
- 数据将鳞状细胞癌和基底细胞癌合并分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As the United States becomes more diverse, determining differences in health care utilization and costs in the management of skin cancers is fundamental to decision-making in health care resource allocation and improving care for underserved populations. OBJECTIVE: To compare health care use and costs among non-Hispanic White, Hispanic White, and non-Hispanic Black patients with keratinocyte carcinoma. METHODS: A nationwide cross-sectional study was performed using Medical Expenditure Panel Survey data from 1996 to 2015. RESULTS: Among 54,503,447 patients with keratinocyte carcinoma (weighted) over a 20-year period, 53,134,351 (97%) were non-Hispanic White; 836,030 (1.5%) were Hispanic White; and 170,755 (0.3%) were non-Hispanic Black. Compared to non-Hispanic White patients, Hispanic White patients had significantly more ambulatory visits per person per year (5.4 vs 3.5, P = .003). Compared to non-Hispanic White patients, non-Hispanic Black patients had significantly more ambulatory visits (13.1 vs 3.5, P = .027) and emergency department visits (2.3 vs 1.1, P < .001), and incurred significantly higher ambulatory costs ($5089 vs $1131, P = .05), medication costs ($523 vs $221, P = .022), and total costs per person per year ($13,430 vs $1290, P = .032). LIMITATIONS: Data for squamous cell carcinomas and basal cell carcinomas are combined. CONCLUSIONS: Keratinocyte carcinoma was more costly to treat and required more health care resources in non-Hispanic Black and Hispanic White patients than in non-Hispanic White patients.
引用
- Sierro TJ, Blumenthal LY, Hekmatjah J, et al. Differences in health care resource utilization and costs for keratinocyte carcinoma among racioethnic groups: A population-based study. J Am Acad Dermatol. 2021. PMID: 34246700. doi:10.1016/j.jaad.2021.07.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。